Publication
A Multinational Study of Acute and Long‐Term Outcomes of Type 1 Galactosemia Patients Who Carry the S135L (c.404C > T) Variant of GALT
dc.contributor.author | Katler, Q | |
dc.contributor.author | Stepien, K | |
dc.contributor.author | Paull, N | |
dc.contributor.author | Patel, S | |
dc.contributor.author | Adams, M | |
dc.contributor.author | Balci, M | |
dc.contributor.author | Berry, G | |
dc.contributor.author | Bosch, A | |
dc.contributor.author | DeLaO, A | |
dc.contributor.author | Demirbas, D | |
dc.contributor.author | Edman, J | |
dc.contributor.author | Ficicioglu, C | |
dc.contributor.author | Goff, M | |
dc.contributor.author | Hacker, S | |
dc.contributor.author | Knerr, I | |
dc.contributor.author | Lancaster, K | |
dc.contributor.author | Li, H | |
dc.contributor.author | Mendelsohn, B | |
dc.contributor.author | Nichols, B | |
dc.contributor.author | Rezende Pinto, W | |
dc.contributor.author | César Rocha, J | |
dc.contributor.author | Rubio‐Gozalbo, ME | |
dc.contributor.author | Saad‐Naguib, M | |
dc.contributor.author | Scholl‐Buergi, S | |
dc.contributor.author | Searcy, S | |
dc.contributor.author | Souza, P | |
dc.contributor.author | Wittenauer, A | |
dc.contributor.author | Fridovich‐Keil, J | |
dc.date.accessioned | 2023-10-09T14:32:54Z | |
dc.date.available | 2023-10-09T14:32:54Z | |
dc.date.issued | 2022-11 | |
dc.description.abstract | Patients with galactosemia who carry the S135L (c.404C > T) variant of galactose-1-P uridylyltransferase (GALT), documented to encode low-level residual GALT activity, have been under-represented in most prior studies of outcomes in Type 1 galactosemia. What is known about the acute and long-term outcomes of these patients, therefore, is based on very limited data. Here, we present a study comparing acute and long-term outcomes of 12 patients homozygous for S135L, 25 patients compound heterozygous for S135L, and 105 patients homozygous for two GALT-null (G) alleles. This is the largest cohort of S135L patients characterized to date. Acute disease following milk exposure in the newborn period was common among patients in all 3 comparison groups in our study, as were long-term complications in the domains of speech, cognition, and motor outcomes. In contrast, while at least 80% of both GALT-null and S135L compound heterozygous girls and women showed evidence of an adverse ovarian outcome, prevalence was only 25% among S135L homozygotes. Further, all young women in this study with even one copy of S135L achieved spontaneous menarche; this is true for only about 33% of women with classic galactosemia. Overall, we observed that while most long-term outcomes trended milder among groups of patients with even one copy of S135L, many individual patients, either homozygous or compound heterozygous for S135L, nonetheless experienced long-term outcomes that were not mild. This was true despite detection by newborn screening and both early and life-long dietary restriction of galactose. This information should empower more evidence-based counseling for galactosemia patients with S135L. | pt_PT |
dc.description.version | info:eu-repo/semantics/publishedVersion | pt_PT |
dc.identifier.citation | J Inherit Metab Dis . 2022 Nov;45(6):1106-1117. | pt_PT |
dc.identifier.doi | 10.1002/jimd.12556 | pt_PT |
dc.identifier.uri | http://hdl.handle.net/10400.17/4715 | |
dc.language.iso | eng | pt_PT |
dc.peerreviewed | yes | pt_PT |
dc.publisher | Wiley | pt_PT |
dc.subject | HCC END | pt_PT |
dc.subject | Humans | pt_PT |
dc.subject | Female | pt_PT |
dc.subject | Alleles | pt_PT |
dc.subject | Galactose | pt_PT |
dc.subject | Galactosemias* / diagnosis | pt_PT |
dc.subject | Galactosemias* / genetics | pt_PT |
dc.subject | Homozygote | pt_PT |
dc.subject | Infant, Newborn | pt_PT |
dc.subject | UTP-Hexose-1-Phosphate Uridylyltransferase / genetics | pt_PT |
dc.title | A Multinational Study of Acute and Long‐Term Outcomes of Type 1 Galactosemia Patients Who Carry the S135L (c.404C > T) Variant of GALT | pt_PT |
dc.type | journal article | |
dspace.entity.type | Publication | |
oaire.citation.endPage | 1117 | pt_PT |
oaire.citation.issue | 6 | pt_PT |
oaire.citation.startPage | 1106 | pt_PT |
oaire.citation.title | Journal of Inherited Metabolic Disease | pt_PT |
oaire.citation.volume | 45 | pt_PT |
rcaap.rights | openAccess | pt_PT |
rcaap.type | article | pt_PT |